BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37741962)

  • 41. Isolation of Alginate-Degrading Bacteria from the Human Gut Microbiota and Discovery of
    Fu T; Wang Y; Ma M; Dai W; Pan L; Shang Q; Yu G
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial.
    Lai H; Li Y; He Y; Chen F; Mi B; Li J; Xie J; Ma G; Yang J; Xu K; Liao X; Yin Y; Liang J; Kong L; Wang X; Li Z; Shen Y; Dang S; Zhang L; Wu Q; Zeng L; Shi L; Zhang X; Tian T; Liu X
    Gut Microbes; 2023; 15(1):2197837. PubMed ID: 37078654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carboxymethyl chitosan microspheres loaded hyaluronic acid/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease.
    Zhang S; Kang L; Hu S; Hu J; Fu Y; Hu Y; Yang X
    Int J Biol Macromol; 2021 Jan; 167():1598-1612. PubMed ID: 33220374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of dietary fiber on inflammatory bowel disease.
    Galvez J; Rodríguez-Cabezas ME; Zarzuelo A
    Mol Nutr Food Res; 2005 Jun; 49(6):601-8. PubMed ID: 15841496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome.
    Berentsen B; Nagaraja BH; Teige EP; Lied GA; Lundervold AJ; Lundervold K; Steinsvik EK; Hillestad ER; Valeur J; Brønstad I; Gilja OH; Osnes B; Hatlebakk JG; Haász J; Labus J; Gupta A; Mayer EA; Benitez-Páez A; Sanz Y; Lundervold A; Hausken T
    Medicine (Baltimore); 2020 Sep; 99(37):e21950. PubMed ID: 32925728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dietary Fiber Hierarchical Specificity: the Missing Link for Predictable and Strong Shifts in Gut Bacterial Communities.
    Cantu-Jungles TM; Bulut N; Chambry E; Ruthes A; Iacomini M; Keshavarzian A; Johnson TA; Hamaker BR
    mBio; 2021 Jun; 12(3):e0102821. PubMed ID: 34182773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incorporating inulin and chitosan in alginate-based microspheres for targeted delivery and release of quercetin to colon.
    Liu S; Fang Z; Ng K
    Food Res Int; 2022 Oct; 160():111749. PubMed ID: 36076471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel Gut Microbiota Patterns Involved in the Attenuation of Dextran Sodium Sulfate-Induced Mouse Colitis Mediated by Glycerol Monolaurate via Inducing Anti-inflammatory Responses.
    Mo Q; Liu T; Fu A; Ruan S; Zhong H; Tang J; Zhao M; Li Y; Zhu S; Cai H; Feng F
    mBio; 2021 Oct; 12(5):e0214821. PubMed ID: 34634946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Starch Microspheres Entrapped with Chitosan Delay
    Wang S; De Paepe K; Van de Wiele T; Fu X; Yuan Y; Zhang B; Huang Q
    J Agric Food Chem; 2021 Oct; 69(41):12323-12332. PubMed ID: 34623811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dietary Fibre Intervention for Gut Microbiota, Sleep, and Mental Health in Adults with Irritable Bowel Syndrome: A Scoping Review.
    Yan R; Andrew L; Marlow E; Kunaratnam K; Devine A; Dunican IC; Christophersen CT
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34201752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome.
    Spagnuolo R; Cosco C; Mancina RM; Ruggiero G; Garieri P; Cosco V; Doldo P
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):102-107. PubMed ID: 28724171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines.
    Zhou Y; Zhang F; Mao L; Feng T; Wang K; Xu M; Lv B; Wang X
    Eur J Nutr; 2023 Feb; 62(1):139-155. PubMed ID: 35918555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An Elemental Diet Enriched in Amino Acids Alters the Gut Microbial Community and Prevents Colonic Mucus Degradation in Mice with Colitis.
    Zhang B; Zhao C; Zhang X; Li X; Zhang Y; Liu X; Yin J; Li X; Wang J; Wang S
    mSystems; 2022 Dec; 7(6):e0088322. PubMed ID: 36468853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of 2'-Fucosyllactose on Gut Microbiota Composition in Adults with Chronic Gastrointestinal Conditions: Batch Culture Fermentation Model and Pilot Clinical Trial Findings.
    Ryan JJ; Monteagudo-Mera A; Contractor N; Gibson GR
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33799455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening dietary fibres for fermentation characteristics and metabolic profiles using a rapid
    So D; Yao CK; Gill PA; Pillai N; Gibson PR; Muir JG
    Br J Nutr; 2021 Jul; 126(2):208-218. PubMed ID: 33028442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EHealth: self-management in inflammatory bowel disease and in irritable bowel syndrome using novel constant-care web applications. EHealth by constant-care in IBD and IBS.
    Pedersen N
    Dan Med J; 2015 Dec; 62(12):B5168. PubMed ID: 26621403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
    Nakase H; Okazaki K; Tabata Y; Chiba T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children.
    Guandalini S; Cernat E; Moscoso D
    Benef Microbes; 2015; 6(2):209-17. PubMed ID: 25391345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A.
    Li YJ; Chen X; Kwan TK; Loh YW; Singer J; Liu Y; Ma J; Tan J; Macia L; Mackay CR; Chadban SJ; Wu H
    J Am Soc Nephrol; 2020 Jun; 31(6):1267-1281. PubMed ID: 32358041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.